+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Assays - Medical Devices Pipeline Assessment, 2018

  • ID: 4601674
  • Report
  • 79 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • Beckman Coulter Inc
  • Enable Biosciences Inc
  • Johns Hopkins University
  • PortaScience Inc
  • The Forsyth Institute
  • MORE
Diabetes Assays - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2018" provides an overview of Diabetes Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Diabetes Assays pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Diabetes Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Diabetes Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • Beckman Coulter Inc
  • Enable Biosciences Inc
  • Johns Hopkins University
  • PortaScience Inc
  • The Forsyth Institute
  • MORE
1 Table of Contents

2 Introduction
2.1 Diabetes Assays Overview

3 Products under Development
3.1 Diabetes Assays - Pipeline Products by Stage of Development
3.2 Diabetes Assays - Pipeline Products by Segment
3.3 Diabetes Assays - Pipeline Products by Territory
3.4 Diabetes Assays - Pipeline Products by Regulatory Path
3.5 Diabetes Assays - Pipeline Products by Estimated Approval Date

4 Diabetes Assays - Pipeline Products under Development by Companies
4.1 Diabetes Assays Companies - Pipeline Products by Stage of Development
4.2 Diabetes Assays - Pipeline Products by Stage of Development

5 Diabetes Assays Companies and Product Overview
5.1 Abcodia Ltd Company Overview
5.2 Abionic SA Company Overview
5.3 Achira Labs Pvt Ltd Company Overview
5.4 Adaptive Biotechnologies Corp Company Overview
5.5 Alfa Wassermann Inc Company Overview
5.6 Aura Biotechnologies Pvt Ltd Company Overview
5.7 Beckman Coulter Inc Company Overview
5.8 Biocrates Life Sciences AG Company Overview
5.9 Caprion Biosciences Inc Company Overview
5.10 Drexel University Company Overview
5.11 ELITechGroup Inc Company Overview
5.12 Enable Biosciences Inc Company Overview
5.13 Fujirebio Diagnostics Inc Company Overview
5.14 Genalyte Inc Company Overview
5.15 Helmholtz Centre for Infection Research Company Overview
5.16 ImmusanT Inc Company Overview
5.17 Janssen Pharmaceuticals Inc Company Overview
5.18 Johns Hopkins University Company Overview
5.19 Mellitus, LLC Company Overview
5.20 Mindray Medical International Ltd Company Overview
5.21 Numares AG Company Overview
5.22 Ortho-Clinical Diagnostics Inc Company Overview
5.23 PeriRx Inc Company Overview
5.24 PortaScience Inc Company Overview
5.25 Protagen AG Company Overview
5.26 Queen Mary University of London Company Overview
5.27 QuickCheck Health Inc Company Overview
5.28 Singulex Inc Company Overview
5.29 The Forsyth Institute Company Overview
5.30 University of Canterbury Company Overview
5.31 University of Colorado Company Overview
5.32 University of Florida Company Overview
5.33 University of South Florida Company Overview
5.34 Xhale Inc Company Overview
5.35 Yaathum Biotech Pvt Ltd Company Overview

6 Diabetes Assays- Recent Developments
6.1 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics
6.2 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
6.3 Jan 25, 2018: Proteomics International Laboratories: Quarterly Business Update
6.4 Nov 22, 2017: Proteomics International strengthens Board and Business Development team
6.5 Oct 20, 2017: Asahi Kasei Pharma received 510(k) clearance from the FDA for Lucica Glycated Albumin-L
6.6 Oct 05, 2017: Mercodia Akurio Multiplex Used in a Recently Published Article
6.7 Aug 29, 2017: New technology could predict the risk of type 2 diabetes
6.8 Aug 16, 2017: HealPros and BioIQ Collaborate to Deliver a Comprehensive Diabetes Care Gap Closure Solution to Help Health Plans Improve Quality Ratings
6.9 Jul 18, 2017: Australian-first at-home blood test helping researchers delay and prevent onset of type 2 diabetes
6.10 Jul 18, 2017: Oramed Pharmaceuticals appoints vice president of medical affairs
6.11 Jul 17, 2017: EKF publish new diabetes and HbA1c testing guide

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Diabetes Assays - Pipeline Products by Stage of Development
Table 2: Diabetes Assays - Pipeline Products by Segment
Table 3: Diabetes Assays - Pipeline Products by Territory
Table 4: Diabetes Assays - Pipeline Products by Regulatory Path
Table 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
Table 6: Diabetes Assays Companies - Pipeline Products by Stage of Development
Table 7: Diabetes Assays - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Biomarker - Diabetes - Product Status
Table 10: Molecular Biomarker - Diabetes - Product Description
Table 11: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: IVD CAPSULE - Diabetes Test - Product Status
Table 13: IVD CAPSULE - Diabetes Test - Product Description
Table 14: Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Diabetes Panel - Product Status
Table 16: Diabetes Panel - Product Description
Table 17: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status
Table 19: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description
Table 20: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Status
Table 22: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Description
Table 23: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: AURA Quant Glargine ELISA Kit - Product Status
Table 25: AURA Quant Glargine ELISA Kit - Product Description
Table 26: AURA Quant Human C-peptide Kit - Product Status
Table 27: AURA Quant Human C-peptide Kit - Product Description
Table 28: AURA Quant Human Insulin ELISA Kit - Product Status
Table 29: AURA Quant Human Insulin ELISA Kit - Product Description
Table 30: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: AU480 Clinical System - Next Generation HbA1c Assay - Product Status
Table 32: AU480 Clinical System - Next Generation HbA1c Assay - Product Description
Table 33: AU5810 Clinical System - Next-generation HbA1c Assay - Product Status
Table 34: AU5810 Clinical System - Next-generation HbA1c Assay - Product Description
Table 35: AU5820 Clinical System - Next-generation HbA1c Assay - Product Status
Table 36: AU5820 Clinical System - Next-generation HbA1c Assay - Product Description
Table 37: AU5830 Clinical System - Next-generation HbA1c Assay - Product Status
Table 38: AU5830 Clinical System - Next-generation HbA1c Assay - Product Description
Table 39: AU5840 Clinical System - Next-generation HbA1c Assay - Product Status
Table 40: AU5840 Clinical System - Next-generation HbA1c Assay - Product Description
Table 41: AU680 Clinical System - Next-generation HbA1c Assay - Product Status
Table 42: AU680 Clinical System - Next-generation HbA1c Assay - Product Description
Table 43: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Diagnostic Assay - Type 2 Diabetes - Product Status
Table 45: Diagnostic Assay - Type 2 Diabetes - Product Description
Table 46: Metabolomic Biomarker Assay - Diabetes - Product Status
Table 47: Metabolomic Biomarker Assay - Diabetes - Product Description
Table 48: Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Diagnostic Assay - Gestational Diabetes Progression - Product Status
Table 50: Diagnostic Assay - Gestational Diabetes Progression - Product Description
Table 51: Diagnostic Assay - Islet Cell Health - Product Status
Table 52: Diagnostic Assay - Islet Cell Health - Product Description
Table 53: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Diagnostic Assay - Diabetic Ulcers - Product Status
Table 55: Diagnostic Assay - Diabetic Ulcers - Product Description
Table 56: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Eon 100 Automated Chemistry Analyzer - Hemoglobin A1c Assay - Product Status
Table 58: Eon 100 Automated Chemistry Analyzer - Hemoglobin A1c Assay - Product Description
Table 59: Eon 300 Automated Chemistry Analyzer - Hemoglobin A1c Assay - Product Status
Table 60: Eon 300 Automated Chemistry Analyzer - Hemoglobin A1c Assay - Product Description
Table 61: Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: ADAP Type1 Diabetes Assay - Product Status
Table 63: ADAP Type1 Diabetes Assay - Product Description
Table 64: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Lumipulse G C-Peptide Assay Kit - Product Status
Table 66: Lumipulse G C-Peptide Assay Kit - Product Description
Table 67: Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Maverick Type 1 Diabetes (T1D) Assay Kit - Product Status
Table 69: Maverick Type 1 Diabetes (T1D) Assay Kit - Product Description
Table 70: Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Diagnostic Biomarker -Type 2 Diabetes - Product Status
Table 72: Diagnostic Biomarker -Type 2 Diabetes - Product Description
Table 73: ImmusanT Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Diagnostic Test - Type 1 Diabetes - Product Status
Table 75: Diagnostic Test - Type 1 Diabetes - Product Description
Table 76: Janssen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Diagnostic Biomarker - Beta-cell Function - Product Status
Table 78: Diagnostic Biomarker - Beta-cell Function - Product Description
Table 79: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Screening Test - Gestational Diabetes - Product Status
Table 81: Screening Test - Gestational Diabetes - Product Description
Table 82: Mellitus, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Blood Test - Gestational Diabetes - Product Status
Table 84: Blood Test - Gestational Diabetes - Product Description
Table 85: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 86: CL-2000i - C-peptide Test - Product Status
Table 87: CL-2000i - C-peptide Test - Product Description
Table 88: CL-2000i - Insulin Test - Product Status
Table 89: CL-2000i - Insulin Test - Product Description
Table 90: Numares AG Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Diagnostic Test - Diabetes - Product Status
Table 92: Diagnostic Test - Diabetes - Product Description
Table 93: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 94: VITROS 3600 - Insulin Assay - Product Status
Table 95: VITROS 3600 - Insulin Assay - Product Description
Table 96: Vitros 4600/5,1 FS Chemistry System - Beta Hydroxybutrate Assay - Product Status
Table 97: Vitros 4600/5,1 FS Chemistry System - Beta Hydroxybutrate Assay - Product Description
Table 98: Vitros 5600 Integrated System - Beta Hydroxybutrate Assay - Product Status
Table 99: Vitros 5600 Integrated System - Beta Hydroxybutrate Assay - Product Description
Table 100: Vitros ECi - C-Peptide Assay - Product Status
Table 101: Vitros ECi - C-Peptide Assay - Product Description
Table 102: Vitros ECi - Insulin Assay - Product Status
Table 103: Vitros ECi - Insulin Assay - Product Description
Table 104: Vitros Insulin Assay - Product Status
Table 105: Vitros Insulin Assay - Product Description
Table 106: PeriRx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 107: SaliMark D2 - Product Status
Table 108: SaliMark D2 - Product Description
Table 109: PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 110: HbA1c Blood Test - Product Status

List of Figures
Figure 1: Diabetes Assays - Pipeline Products by Stage of Development
Figure 2: Diabetes Assays - Pipeline Products by Segment
Figure 3: Diabetes Assays - Pipeline Products by Territory
Figure 4: Diabetes Assays - Pipeline Products by Regulatory Path
Figure 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abcodia Ltd
  • Abionic SA
  • Achira Labs Pvt Ltd
  • Adaptive Biotechnologies Corp
  • Alfa Wassermann Inc
  • Aura Biotechnologies Pvt Ltd
  • Beckman Coulter Inc
  • Biocrates Life Sciences AG
  • Caprion Biosciences Inc
  • Drexel University
  • ELITechGroup Inc
  • Enable Biosciences Inc
  • Fujirebio Diagnostics Inc
  • Genalyte Inc
  • Helmholtz Centre for Infection Research
  • ImmusanT Inc
  • Janssen Pharmaceuticals Inc
  • Johns Hopkins University
  • Mellitus, LLC
  • Mindray Medical International Ltd
  • Numares AG
  • Ortho-Clinical Diagnostics Inc
  • PeriRx Inc
  • PortaScience Inc
  • Protagen AG
  • Queen Mary University of London
  • QuickCheck Health Inc
  • Singulex Inc
  • The Forsyth Institute
  • University of Canterbury
  • University of Colorado
  • University of Florida
  • University of South Florida
  • Xhale Inc
  • Yaathum Biotech Pvt Ltd
Note: Product cover images may vary from those shown
Adroll
adroll